Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis

Chen Huang, Keping Xie

Research output: Contribution to journalReview articlepeer-review

64 Scopus citations

Abstract

Pancreatic cancer progression is attributed to genetic and epigenetic alterations and a chaotic tumor microenvironment. Those diverse " upstream signal" factors appear to converge on specific sets of central nuclear regulators, namely, transcription factors. Specificity Protein 1 (Sp1) and signal transducer and activator of transcription 3 (Stat3) are central transcription factors that regulate a number of pathways important to tumorigenesis, including tumor cell-cycle progression, apoptosis, angiogenesis, metastasis, and evasion of the immune system. Recently, researchers demonstrated many types of crosstalk of Sp1 and Stat3 in tumor signal transduction and that these factors function cooperatively to activate targeted genes and promote tumorigenesis in pancreatic cancer. Therefore, targeting both Sp1 and Stat3 is a potential preventive and therapeutic strategy for pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)25-35
Number of pages11
JournalCytokine and Growth Factor Reviews
Volume23
Issue number1-2
DOIs
StatePublished - Feb 2012

Keywords

  • Angiogenesis
  • Metastasis
  • Therapy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Immunology
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis'. Together they form a unique fingerprint.

Cite this